Carpal tunnel syndrome is twice as common in the 2 or more years preceding a diagnosis of rheumatoid arthritis, according to ...

There's a potential new alternative treatment for people with rheumatoid arthritis, an often debilitating condition. Stephanie Stahl reports more about the new research.

The funding round saw participation from new investors Bold Capital and Bold Longevity Growth Fund, alongside previous ...

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) ...

Rheumatoid arthritis (RA) is a chronic autoimmune disease that affects individuals across all ages and genders.

AnaptysBio’s lead drug rosnilimab showed promise in RA, but lack of a Phase 3 plan and limited pipeline raise concerns. Find ...

As the nature of bees suggests, good and bad mingle. Painful stings, but beautiful pollination that boosts crops. The enzyme and main allergen, phospholipase A2, causes swelling and cell damage, but ...

Scipher Medicine, a leader in precision immunology, and Savant Bio, a Roivant-backed health data infrastructure company, today announced an expanded strategic partnership to build the world’s most ...

The diagnosis of several of them can be aided by blood tests and/or imaging. There may not be a cure, but with lifestyle ...

Dr. Zuraw led clinical development of telitacicept across MG, Sjögren’s, SLE, and RA at RemeGen, resulting in multiple ...

A new study published in the journal of Arthritis & Rheumatology showed that Janus kinase (JAK) inhibitors did not increase ...

A panelist discusses how given PODIUM-303's benefits across all subgroups, the primary patient population that should receive chemotherapy alone rather than the combination with retifanlimab would be ...